Not all cancers respond strongly—or at all—to immunotherapies. The more responsive cancers include “hot” tumors, which have many intratumoral T cells, whereas the less responsive cancers, such as ...
Nov. 26, 2024 — Cancer cells on the surface are thought to have natural advantages compared to cells deep within, which is why scientists have hypothesized tumors grow more in their periphery ...
Chromosomal Chaos Promotes Therapy Resistance in Leukemia Cells and Opens Up New Treatment Approaches Nov. 25, 2024 — Chromosomal instability plays a crucial role in the progression of cancer ...
A research team from the Shanghai Institute of Nutrition and Health (SINH) of the Chinese Academy of Sciences has revealed that aging specifically impairs the generation of CD8+ tissue resident memory ...
The cancer microenvironment, or tumour microenvironment, describes the non-cancerous cells present in the tumour. These include fibroblasts, immune cells and cells that comprise the blood vessels.
A precancerous cell is a cell with certain abnormalities that makes it more likely to become cancerous. These abnormalities don't mean that it will become cancer—in fact, most don't—but the diagnosis ...
proteins expressed by cancer cells. Other cancer immunotherapies include vaccines and T cell infusions. Immune checkpoint inhibitors have shown some activity in patients with adrenocortical ...